You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 8,047,202


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,047,202
Title:Nasal devices
Abstract: A nasal delivery device and a method of delivering substance to a nasal airway of a subject, can be used for mass treatment, especially mass vaccination. The delivery device can include an interface unit, as a replaceable unit, having at least one nosepiece unit for fitting to a respective nostril of a subject, a nozzle from which substance is in use delivered, and at least one delivery unit having a substance supply unit for delivering substance to the nozzle of the at least one nosepiece unit. The delivery device can also include an actuation unit for actuating the at least one delivery unit of the interface unit.
Inventor(s): Djupesland; Per Gisle (Oslo, NO)
Assignee: OptiNose AS (Oslo, NO)
Application Number:12/339,716
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,047,202: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the details of United States Patent 8,047,202, exploring its claims, scope, and the broader patent landscape it inhabits.

Background of the Patent

United States Patent 8,047,202, hereafter referred to as the '202 patent, is a utility patent that was granted on November 1, 2011. To analyze this patent, it is essential to understand the context in which it was filed and the technological area it pertains to.

Claims of the Patent

The claims of a patent are its most critical components, as they define the scope of the invention and what is protected by the patent. Here are some key points to consider:

Independent Claims

Independent claims are those that stand alone and do not depend on other claims. They typically define the broadest scope of the invention. For the '202 patent, identifying the independent claims is crucial for understanding the core of the invention.

Dependent Claims

Dependent claims build upon the independent claims and provide additional limitations or details. These claims help to narrow down the scope of the invention and can offer additional protection by covering specific embodiments or variations of the invention.

Scope of the Patent

The scope of a patent is determined by its claims and the description provided in the specification. Here are some aspects to consider:

Technical Field

Understanding the technical field in which the patent operates is vital. This includes identifying the industry, the specific technology, and how the invention fits into existing solutions.

Prior Art

Prior art refers to the existing body of knowledge in the field at the time the patent was filed. Analyzing prior art helps in understanding how the '202 patent innovates and differs from what was already known.

Patent Landscape Analysis

A patent landscape analysis involves examining the broader context of patents related to the '202 patent. Here are some key elements:

Claim Coverage Matrix

Using a Claim Coverage Matrix, as described in patent analytics, helps in categorizing patents by claims and scope concepts. This tool can identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Related Patents and Applications

Identifying related patents and applications, including continuations, continuations-in-part, and divisional applications, is crucial. This can be done using tools like the USPTO's Patent Public Search and Global Dossier services[4].

International Patent Family

Checking the international patent family through services like the Common Citation Document (CCD) and PATENTSCOPE by WIPO can provide a global perspective on the patent's coverage and any related applications filed in other jurisdictions[4].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue in patent law, particularly when dealing with patents that have been granted Patent Term Adjustment (PTA). The Federal Circuit has ruled that ODP analysis must consider the adjusted expiration date of the patent, ensuring that an inventor does not secure a second, later-expiring patent for the same invention[1].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. These disclaimers ensure that the term of a later-granted patent does not extend beyond the term of an earlier-granted patent covering the same invention. This is particularly relevant if the '202 patent is part of a family of patents with varying expiration dates due to PTA[1].

Practical Applications and Future Directions

Understanding the practical applications of the '202 patent involves looking at how it is used in industry and any potential future directions. This can include:

Claim Charts and Technical Expert Review

Using claim charts to review patent coverage with engineers, scientists, and management can help in determining whether the scope concepts of the patent claims are applicable to target products or methods. This approach also highlights gaps in current coverage and future design opportunities[3].

Market Impact and Competitor Analysis

Analyzing the market impact of the '202 patent and how it positions the patent holder relative to competitors is essential. This involves looking at the broader industry landscape and identifying any trends or innovations that the patent might influence.

Legal and Policy Considerations

The legal and policy framework surrounding the '202 patent is also important:

Small Claims Patent Court

The concept of a small claims patent court, as studied by ACUS, could potentially impact how disputes related to the '202 patent are handled. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[2].

Enablement and Patentability

Ensuring that the '202 patent meets the requirements of enablement and patentability is crucial. The USPTO's guidelines on assessing enablement in utility applications can provide valuable insights into how the patent's specification supports its claims[5].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is essential for defining the scope of the invention.
  • Patent Landscape: Analyzing related patents and applications helps in identifying gaps and opportunities.
  • ODP and Terminal Disclaimers: Ensuring compliance with ODP and using terminal disclaimers if necessary is critical for maintaining patent validity.
  • Practical Applications: Reviewing claim charts with technical experts and analyzing market impact are vital for maximizing the patent's value.
  • Legal Considerations: Staying updated with legal and policy changes, such as the potential for a small claims patent court, is important for navigating patent disputes.

FAQs

Q: What is the significance of independent claims in a patent?

A: Independent claims define the broadest scope of the invention and are crucial for understanding what is protected by the patent.

Q: How does ODP affect patents with PTA?

A: ODP analysis must consider the adjusted expiration date of the patent to prevent an inventor from securing a second, later-expiring patent for the same invention.

Q: What is the purpose of a Claim Coverage Matrix?

A: A Claim Coverage Matrix helps in categorizing patents by claims and scope concepts, identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist.

Q: Why is it important to analyze the international patent family of a patent?

A: Analyzing the international patent family provides a global perspective on the patent's coverage and any related applications filed in other jurisdictions.

Q: How can a small claims patent court impact patent disputes?

A: A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes, making it easier for smaller entities to enforce their patent rights.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent Small Claims Court, Administrative Conference of the United States.
  3. Patent Analytics, Schwegman Lundberg & Woessner, P.A.
  4. Search for Patents, United States Patent and Trademark Office.
  5. Guidelines for Assessing Enablement in Utility Applications, Federal Register, January 10, 2024.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,047,202

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,047,202

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0215270.0Jul 2, 2002

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.